Literature DB >> 27261854

Anti-Toxoplasma antibodies prevalence and associated risk factors among HIV patients.

Dechassa Tegegne1, Mukarim Abdurahaman2, Tadesse Mosissa3, Moti Yohannes2.   

Abstract

OBJECTIVES: To assess the seroprevalence and associated risk factors of toxoplasmosis among HIV patients in Agaro Town Health Center of Jimma zone.
METHODS: Convenient sampling was used to collect blood samples from 135 patients attending anti-retroviral therapy from February to March 2015. Serum samples were tested for anti-Toxoplasma gondii (T. gondii) antibody by using latex agglutination test. Structured questionnaire was used to collect data on socio-demographic and risk factors associated with toxoplasmosis.
RESULTS: Overall seroprevalence of toxoplasmosis was 80.7% (109/135, CI: 74.04-87.36). In multivariate analysis significant association was observed between anti-T. gondii seropositivity and raw meat consumption (OR: 3.514, CI: 1.167-10.581, P = 0.025), knowledge about toxoplasmosis (OR: 5.225, CI: 1.382, P = 0.015) and sex (OR: 4.023, CI: 1.382-19.762, P = 0.015).
CONCLUSIONS: Immuno compromised patients showed high rate of seropositivity and thus, it is highly advisable to introduce routine anti-T. gondii antibodies serological screening test prior to ART commencement.
Copyright © 2016 Hainan Medical College. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HIV; LAT; Seroprevalence; Toxoplasma gondii

Year:  2016        PMID: 27261854     DOI: 10.1016/j.apjtm.2016.03.034

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  8 in total

1.  Seroepidemiology and associated risk factors of Toxoplasma gondii in sheep and goats in Southwestern Ethiopia.

Authors:  Dechassa Tegegne; Amin Kelifa; Mukarim Abdurahaman; Moti Yohannes
Journal:  BMC Vet Res       Date:  2016-12-09       Impact factor: 2.741

2.  Activation of chronic toxoplasmosis by transportation stress in a mouse model.

Authors:  Bang Shen; Yuan Yuan; Jianxi Cheng; Ming Pan; Ningbo Xia; Weichao Zhang; Yifan Wang; Yanqin Zhou; Junlong Zhao
Journal:  Oncotarget       Date:  2016-12-27

3.  Seroprevalence of Toxoplasma gondii among pregnant women attending antenatal clinics at Hawassa University comprehensive specialized and Yirgalem General Hospitals, in Southern Ethiopia.

Authors:  Demissie Assegu Fenta
Journal:  BMC Infect Dis       Date:  2019-12-16       Impact factor: 3.090

4.  Research on demographic, clinical and paraclinical aspects in pregnant women infected with Toxoplasma gondii.

Authors:  Andrei Csep; Luminița Ligia Vaida; Bianca-Maria Negruțiu; Bianca Ioana Todor; Claudia Teodora Judea-Pusta; Camelia Buhaș; Cristian Sava
Journal:  Exp Ther Med       Date:  2021-12-07       Impact factor: 2.447

5.  Seronegative Infection with Toxoplasma gondii in Asymptomatic Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Patients and in Blood Donors.

Authors:  Agnieszka Pawełczyk; Małgorzata Bednarska; Kamila Caraballo Cortés; Marianna Glamkowska-Sady; Justyna Kowalska; Beata Uszyńska-Kałuża; Marek Radkowski; Renata Welc-Falęciak
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

6.  Investigating the risk factors for seroprevalence and the correlation between CD4+ T-cell count and humoral antibody responses to Toxoplasma gondii infection amongst HIV patients in the Bamenda Health District, Cameroon.

Authors:  Eugene Enah Fang; Raymond Babila Nyasa; Emmanuel Menang Ndi; Denis Zofou; Tebit Emmanuel Kwenti; Edith Pafoule Lepezeu; Vincent P K Titanji; Roland N Ndip
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

Review 7.  Toxoplasmosis in Pregnant Women and HIV/AIDS Patients in Ethiopia: A Systematic Review and Meta-Analysis.

Authors:  Daniel Getacher Feleke; Angesom Gebreweld; Gashaw Zewde
Journal:  J Parasitol Res       Date:  2019-10-01

8.  Prevalence and predictors of Toxoplasma gondii infection in pregnant women from Dhamar, Yemen.

Authors:  Abdulelah H Al-Adhroey; Amat Al-Khaleq O Mehrass; Abdulqawi A Al-Shammakh; Abdullatif D Ali; Mohammed Y M Akabat; Hesham M Al-Mekhlafi
Journal:  BMC Infect Dis       Date:  2019-12-30       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.